Related Experiment Video

Updated: Jul 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease

Ahmet Yildiz1, M Akif Cakar, Murat Baskurt

  • 1Department of Cardiology, Gazi Hospital, Izmir, Turkey. drayildiz@yahoo.com

Cardiovascular Ultrasound
|January 1, 2008
PubMed

Insights

Atorvastatin therapy significantly improved endothelial function, measured by flow-mediated dilation, in coronary artery disease patients within 12 weeks. This study highlights statins' role beyond cholesterol reduction in cardiovascular health.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Statins are known to improve endothelial function in coronary artery disease (CAD) patients.
  • Beyond cholesterol reduction, statins exert pleiotropic effects including reduced oxidative stress, plaque stabilization, and anti-inflammatory actions.
  • These effects contribute to decreasing coronary heart disease incidence.

Purpose of the Study:

  • To evaluate the impact of atorvastatin therapy on endothelial function in patients diagnosed with CAD.
  • To assess changes in flow-mediated dilation (FMD) as a marker of endothelial function.

Main Methods:

  • A study group of 49 CAD patients (40 men, 9 women; mean age 59 ± 11 years) received 10 mg/day atorvastatin for 12 weeks.
  • Dosage was increased if target cholesterol levels were not met at 6 weeks.
  • Endothelial function was assessed using flow-mediated dilation (FMD) of the brachial artery.

Main Results:

  • Atorvastatin significantly reduced LDL-cholesterol and total cholesterol levels (p < 0.0001) after 12 weeks.
  • A statistically significant improvement in FMD was observed (8.1% to 4.2%, p < 0.001).
  • No significant change was noted in non-endothelium-dependent dilation (NID).

Conclusions:

  • Atorvastatin therapy led to significant improvement in endothelium-derived vasodilation (EBD) within 12 weeks.
  • EBD was assessed non-invasively using brachial artery ultrasonography.
  • No significant changes in non-endothelium-dependent dilation were observed, suggesting a specific effect on endothelial function.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...